SER
SER
AMEX · Biotechnology

Serina Therapeutics Inc.

$2.27
-0.34 (-13.03%)
Analyst Consensus
Strong Buy
6
Analysts
Moderate
Coverage
Buy 5 83%
Hold 1 17%
Sell 0 0%
Price Target
Analyst Price Target +1,099.1% upside
Low Target $16.99
Average Target $27.22
High Target $37.92
Current Price $2.27
Current
$2.27
Target
$27.22
$16.99 $27.22 avg $37.92
Scenario Analysis
Bear Case
$16.99
648.5%
Low target
Base Case
$27.22
+1,099.1%
Avg target
Bull Case
$37.92
+1,570.5%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$7.92
-71.3% from high
52-Week Low
$1.22
+86.1% from low
Target vs 52W High
$27.22
+243.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.9%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +157.7%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.5%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -69.0%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -12.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.5%